US 11701354
Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors
granted A61KA61K31/4985A61K45/06
Quick answer
US patent 11701354 (Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors) held by Relay Therapeutics, Inc. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K31/4985, A61K45/06, A61P, A61P3/00